Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

1.

Prospects for developing an accurate diagnostic biomarker panel for low prevalence cancers.

Firpo MA, Boucher KM, Mulvihill SJ.

Theor Biol Med Model. 2014 Aug 5;11(1):34. [Epub ahead of print]

PMID:
25096727
[PubMed - as supplied by publisher]
Free Article
2.

Genomic classification of the RAS network identifies a personalized treatment strategy for lung cancer.

El-Chaar NN, Piccolo SR, Boucher KM, Cohen AL, Chang JT, Moos PJ, Bild AH.

Mol Oncol. 2014 May 20. pii: S1574-7891(14)00110-0. doi: 10.1016/j.molonc.2014.05.005. [Epub ahead of print]

PMID:
24908424
[PubMed - as supplied by publisher]
3.

A population-based study of childhood cancer survivors' body mass index.

Warner EL, Fluchel M, Wright J, Sweeney C, Boucher KM, Fraser A, Smith KR, Stroup AM, Kinney AY, Kirchhoff AC.

J Cancer Epidemiol. 2014;2014:531958. doi: 10.1155/2014/531958. Epub 2014 Jan 9.

PMID:
24527036
[PubMed]
Free PMC Article
4.

Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trial.

Kinney AY, Boonyasiriwat W, Walters ST, Pappas LM, Stroup AM, Schwartz MD, Edwards SL, Rogers A, Kohlmann WK, Boucher KM, Vernon SW, Simmons RG, Lowery JT, Flores K, Wiggins CL, Hill DA, Burt RW, Williams MS, Higginbotham JC.

J Clin Oncol. 2014 Mar 1;32(7):654-62. doi: 10.1200/JCO.2013.51.6765. Epub 2014 Jan 21.

PMID:
24449229
[PubMed - indexed for MEDLINE]
5.

Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.

Terakedis BE, Anker CJ, Leachman SA, Andtbacka RH, Bowen GM, Sause WT, Grossmann KF, Bowles TL, Noyes RD, Hitchcock YJ, Boucher KM, Shrieve DC.

J Am Acad Dermatol. 2014 Mar;70(3):435-42. doi: 10.1016/j.jaad.2013.10.028. Epub 2013 Dec 24.

PMID:
24373782
[PubMed - indexed for MEDLINE]
6.

Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.

Kendrick ZW, Firpo MA, Repko RC, Scaife CL, Adler DG, Boucher KM, Mulvihill SJ.

HPB (Oxford). 2014 Jul;16(7):670-6. doi: 10.1111/hpb.12199. Epub 2013 Dec 6.

PMID:
24308545
[PubMed - in process]
7.

Isolation of circulating microRNAs from microvesicles found in human plasma.

Quackenbush JF, Cassidy PB, Pfeffer LM, Boucher KM, Hawkes JE, Pfeffer SR, Kopelovich L, Leachman SA.

Methods Mol Biol. 2014;1102:641-53. doi: 10.1007/978-1-62703-727-3_34.

PMID:
24259003
[PubMed - indexed for MEDLINE]
8.

Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma.

Agarwal N, Bellmunt J, Maughan BL, Boucher KM, Choueiri TK, Qu AQ, Vogelzang NJ, Fougeray R, Niegisch G, Albers P, Wong YN, Ko YJ, Sridhar SS, Tantravahi SK, Galsky MD, Petrylak DP, Vaishampayan UN, Mehta AN, Beer TM, Sternberg CN, Rosenberg JE, Sonpavde G.

Clin Genitourin Cancer. 2014 Apr;12(2):130-7. doi: 10.1016/j.clgc.2013.09.002. Epub 2013 Sep 28.

PMID:
24220220
[PubMed - in process]
9.

Levels of fatigue and distress in senior prostate cancer survivors enrolled in a 12-week randomized controlled trial of Qigong.

Campo RA, Agarwal N, LaStayo PC, O'Connor K, Pappas L, Boucher KM, Gardner J, Smith S, Light KC, Kinney AY.

J Cancer Surviv. 2014 Mar;8(1):60-9. doi: 10.1007/s11764-013-0315-5. Epub 2013 Oct 30.

PMID:
24170679
[PubMed - in process]
10.

Effect of brachytherapy technique and patient characteristics on cervical cancer implant dosimetry.

Anker CJ, O'Donnell K, Boucher KM, Gaffney DK.

Med Dosim. 2013 Winter;38(4):430-5. doi: 10.1016/j.meddos.2013.06.001. Epub 2013 Aug 22.

PMID:
23973016
[PubMed - in process]
11.

Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2) -(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micelles.

Kaur I, Terrazas M, Kosak KM, Kern SE, Boucher KM, Shami PJ.

J Pharm Pharmacol. 2013 Sep;65(9):1329-36. doi: 10.1111/jphp.12100. Epub 2013 Jul 10.

PMID:
23927471
[PubMed - indexed for MEDLINE]
12.

Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis.

Gartrell BA, Ying J, Sivendran S, Boucher KM, Choueiri TK, Sonpavde G, Oh WK, Agarwal N, Galsky MD.

Target Oncol. 2013 Jul 13. [Epub ahead of print]

PMID:
23852656
[PubMed - as supplied by publisher]
13.

Metabolic complications with the use of mTOR inhibitors for cancer therapy.

Sivendran S, Agarwal N, Gartrell B, Ying J, Boucher KM, Choueiri TK, Sonpavde G, Oh WK, Galsky MD.

Cancer Treat Rev. 2014 Feb;40(1):190-6. doi: 10.1016/j.ctrv.2013.04.005. Epub 2013 May 16. Review.

PMID:
23684373
[PubMed - indexed for MEDLINE]
14.

Selenium for the prevention of cutaneous melanoma.

Cassidy PB, Fain HD, Cassidy JP Jr, Tran SM, Moos PJ, Boucher KM, Gerads R, Florell SR, Grossman D, Leachman SA.

Nutrients. 2013 Mar 7;5(3):725-49. doi: 10.3390/nu5030725.

PMID:
23470450
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma.

Poruk KE, Firpo MA, Scaife CL, Adler DG, Emerson LL, Boucher KM, Mulvihill SJ.

Pancreas. 2013 Mar;42(2):193-7. doi: 10.1097/MPA.0b013e31825e354d.

PMID:
23407481
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Pooled analysis of phase II trials evaluating weekly or conventional cisplatin as first-line therapy for advanced urothelial carcinoma.

Maughan BL, Agarwal N, Hussain SA, Boucher KM, Von Der Maase H, Kaufman DS, Lorusso V, Moore MJ, Galsky MD, Sonpavde G.

Clin Genitourin Cancer. 2013 Sep;11(3):316-20. doi: 10.1016/j.clgc.2012.12.007. Epub 2013 Jan 16.

PMID:
23332638
[PubMed - indexed for MEDLINE]
17.

The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates.

Poruk KE, Gay DZ, Brown K, Mulvihill JD, Boucher KM, Scaife CL, Firpo MA, Mulvihill SJ.

Curr Mol Med. 2013 Mar;13(3):340-51. Review.

PMID:
23331006
[PubMed - indexed for MEDLINE]
18.

PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.

Bastien RR, Rodríguez-Lescure Á, Ebbert MT, Prat A, Munárriz B, Rowe L, Miller P, Ruiz-Borrego M, Anderson D, Lyons B, Álvarez I, Dowell T, Wall D, Seguí MÁ, Barley L, Boucher KM, Alba E, Pappas L, Davis CA, Aranda I, Fauron C, Stijleman IJ, Palacios J, Antón A, Carrasco E, Caballero R, Ellis MJ, Nielsen TO, Perou CM, Astill M, Bernard PS, Martín M.

BMC Med Genomics. 2012 Oct 4;5:44. doi: 10.1186/1755-8794-5-44.

PMID:
23035882
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.

Enslow MS, Zollinger LV, Morton KA, Butterfield RI, Kadrmas DJ, Christian PE, Boucher KM, Heilbrun ME, Jensen RL, Hoffman JM.

Clin Nucl Med. 2012 Sep;37(9):854-61. doi: 10.1097/RLU.0b013e318262c76a.

PMID:
22889774
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma.

Jahromi MS, Putnam AR, Druzgal C, Wright J, Spraker-Perlman H, Kinsey M, Zhou H, Boucher KM, Randall RL, Jones KB, Lucas D, Rosenberg A, Thomas D, Lessnick SL, Schiffman JD.

Cancer Genet. 2012 Jul-Aug;205(7-8):391-404. doi: 10.1016/j.cancergen.2012.05.012.

PMID:
22868000
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk